Erythromycin
Product Images NDC 50090-4616

2 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 50090-4616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Erythromycin Delayed Release Tablets Usp 1)

FDA Label Image

Label Image (Lbl500904616)

Label Image (Lbl500904616)
Label for Erythromycin 333 mg delayed-release tablets from A-S Medication Solutions. The label notes the presence of the active ingredient erythromycin at 333 mg per tablet, with 30 delayed-release tablets in the package. Storage instructions specify to keep the product at 68 to 77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.